Author | Allissa M. Long, PharmD and Kevin W. Chamberlin, PharmD, FASCP

Articles

Lefamulin (Xenleta) for Community Acquired Bacterial Pneumonia

January 21, 2020

Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.